BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1423963)

  • 41. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence.
    Lin JS; Lui SM; Chen CM; Chang WC
    J Urol; 1992 Aug; 148(2 Pt 1):311-3. PubMed ID: 1635125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humans.
    Wennmalm A; Fitzgerald GA
    Am J Physiol; 1988 Jul; 255(1 Pt 2):H15-8. PubMed ID: 3293469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.
    Reilly IA; Roy L; Fitzgerald GA
    Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1037-9. PubMed ID: 3083991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eicosenoid biosynthesis and platelet function with advancing age.
    Reilly IA; FitzGerald GA
    Thromb Res; 1986 Feb; 41(4):545-54. PubMed ID: 3754355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of oral contraceptives containing 20 and 35 µg ethinyl estradiol on urinary prostacyclin and thromboxane levels in smokers and non-smokers.
    Ploszaj S; Thornton MH; Stanczyk FZ; Mishell DR
    Prim Care Update Ob Gyns; 1998 Jul; 5(4):156. PubMed ID: 10838290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Percutaneous transluminal angioplasty increases thromboxane A2 production in claudicants.
    Rossi P; Kuukasjärvi P; Salenius JP; Tarkka M; Kerttula T; Alanko J; Mucha I; Riutta A
    Prostaglandins Leukot Essent Fatty Acids; 1997 May; 56(5):369-72. PubMed ID: 9175173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of urinary 11-dehydro-thromboxane B
    Simeone P; Boccatonda A; Liani R; Santilli F
    Ageing Res Rev; 2018 Dec; 48():51-78. PubMed ID: 30273676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
    Reilly IA; Doran JB; Smith B; FitzGerald GA
    Circulation; 1986 Jun; 73(6):1300-9. PubMed ID: 2938849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary prostacyclin and thromboxane metabolites in drinking pregnant women and in their infants: relations to the fetal alcohol effects.
    Ylikorkala O; Halmesmäki E; Viinikka L
    Obstet Gynecol; 1988 Jan; 71(1):61-6. PubMed ID: 3275910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease.
    Adatia I; Barrow SE; Stratton PD; Miall-Allen VM; Ritter JM; Haworth SG
    Circulation; 1993 Nov; 88(5 Pt 1):2117-22. PubMed ID: 8222105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of intravenous oxygen on prostacyclin and thromboxane formation in patients with peripheral occlusive arterial disease.
    Stichtenoth DO; Kreutzer FJ; Gutzki FM; Tsikas D; Nowak V; Frölich JC
    Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):211-4. PubMed ID: 11728174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet activation in unstable coronary disease.
    Fitzgerald DJ; Roy L; Catella F; FitzGerald GA
    N Engl J Med; 1986 Oct; 315(16):983-9. PubMed ID: 3531859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
    Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
    Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.
    Adatia I; Barrow SE; Stratton P; Ritter JM; Haworth SG
    Br Heart J; 1993 Feb; 69(2):179-82. PubMed ID: 8435245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet volume and urinary prostanoid metabolites in non-insulin-dependent diabetes mellitus.
    Inui Y; Suehiro T; Kumon Y; Hashimoto K
    J Atheroscler Thromb; 1994; 1(2):108-12. PubMed ID: 9222878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thromboxane biosynthesis and platelet function in type I diabetes mellitus.
    Alessandrini P; McRae J; Feman S; FitzGerald GA
    N Engl J Med; 1988 Jul; 319(4):208-12. PubMed ID: 3292913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
    FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR
    J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin.
    Böger RH; Bode-Böger SM; Schröder EP; Tsikas D; Frölich JC
    J Appl Physiol (1985); 1995 May; 78(5):1832-8. PubMed ID: 7649919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.
    Belton O; Byrne D; Kearney D; Leahy A; Fitzgerald DJ
    Circulation; 2000 Aug; 102(8):840-5. PubMed ID: 10952950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.